RET proto-oncogene is associated with which carcinoma?
**Core Concept**
The RET proto-oncogene is a tumor suppressor gene that encodes a receptor tyrosine kinase. It plays a crucial role in the development and function of the nervous system and is involved in cell signaling pathways that regulate cell growth and division.
**Why the Correct Answer is Right**
The RET proto-oncogene is associated with multiple endocrine neoplasia type 2 (MEN2), a rare genetic disorder that increases the risk of developing certain types of cancer, including medullary thyroid carcinoma (MTC), pheochromocytoma, and parathyroid adenoma. The RET proto-oncogene mutations lead to the formation of a constitutively active tyrosine kinase, which promotes uncontrolled cell proliferation and tumor formation.
**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because the RET proto-oncogene is not associated with pancreatic carcinoma.
**Option B:** This option is incorrect because the RET proto-oncogene is not associated with breast carcinoma.
**Option C:** This option is incorrect because the RET proto-oncogene is not associated with lung carcinoma.
**Clinical Pearl / High-Yield Fact**
It is essential to remember that mutations in the RET proto-oncogene can be inherited in an autosomal dominant pattern, and genetic testing can help identify individuals at risk of developing MEN2-related cancers.
**Correct Answer: D. Multiple endocrine neoplasia type 2 (MEN2).**